查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1580065

胱胺酸尿市场：按类型、产品、给药途径、最终用户分类 - 全球预测 2025-2030

Cystinuria Market by Type (Type I, Type II, Type III), Offering (Medications, Therapy), Route of Administration, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年胱胺酸尿市值为1.0156亿美元，预计到2024年将达到1.0629亿美元，复合年增长率为4.82%，到2030年将达到1.413亿美元。

胱胺酸尿症是一种遗传性疾病，其特征是在肾臟中形成胱胺酸结石，在更广泛的肾臟病学和泌尿系统治疗领域提出了目标市场。解决胱胺酸尿症的必要性源自于其慢性性质和肾结石復发的可能性，如果治疗不当，可能会导致肾臟损伤。范围主要包括硫醇药物、水合疗法和旨在减少胱胺酸结石形成的饮食管理产品等医药产品。最终用途范围从医院和诊所到专业药房，受患者特定治疗和持续管理需求的驱动。

主要市场统计
基准年[2023] 10156万美元
预测年份 [2024] 1.0629亿美元
预测年份 [2030] 1.413 亿美元
复合年增长率（%） 4.82%

市场成长受到遗传疾病盛行率上升、基因检测进步以及肾臟健康医疗保健意识增强的影响。然而，与其他肾臟疾病相比，它面临着对胱胺酸尿症的认识较低、基因治疗成本高昂以及报销政策不足等挑战，尤其是在新兴市场。治疗机会在于加强以患者为中心的治疗模式、开发非侵入性诊断以及利用远端医疗进行患者管理以推动市场向前发展。公司可以透过投资新疗法的研发来利用这些趋势，特别是那些具有更高功效和安全性的疗法。此外，透过促进与医疗保健提供者和医疗机构的合作，我们可以透过教育措施和全面护理计划来提高市场渗透率。

遗传分析和个人化医疗的创新有望推动胱胺酸尿症治疗的进步。将人工智慧整合到疾病管理的预测模型中是一个令人兴奋的研究途径。儘管该市场是利基市场，但其本质要求高度专业化和技术进步，儘管存在进入壁垒，但现有参与者和创新的新进入者仍有显着增长的潜力。企业可以透过瞄准新兴市场的扩张机会、提高供应链效率以及透过全面的市场教育提高渗透率来实现成长。策略建议包括专注于降低成本策略，以应对报销挑战并增强可及性和市场扩张。

市场动态：揭示快速发展的胱胺酸尿市场的关键市场洞察

供需的动态交互作用正在改变胱胺酸尿市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 被诊断出患有胱胺酸尿症的人数增加
    • 对基因研究和诊断技术的大量投资
  • 市场限制因素
    • 与药物治疗和频繁就诊相关的高成本胱胺酸尿症
  • 市场机会
    • 开发能够快速准确检测胱胺酸尿症的诊断工具
    • 政府透过优惠政策支持罕见疾病研究
  • 市场挑战
    • 对用于治疗胱胺酸尿症的先进治疗方法认识不足

波特的五力：驾驭胱胺酸尿市场的策略工具

波特的五力框架是了解胱胺酸尿市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解胱胺酸尿市场的外部影响

外部宏观环境因素在塑造胱胺酸尿市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解胱胺酸尿市场的竞争状况

对胱氨酸尿市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵胱胺酸尿市场供应商绩效评估

FPNV定位矩阵是评估胱胺酸尿市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製胱胺酸尿市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，胱胺酸尿市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 越来越多的人被诊断出患有胱胺酸尿症
      • 对基因研究和诊断技术的大量投资
    • 抑制因素
      • 与药物治疗和频繁就医相关的高额费用
    • 机会
      • 开发诊断工具以更快、更准确地检测胱胺酸尿症
      • 政府透过优惠政策支持罕见疾病研究
    • 任务
      • 对治疗胱胺酸尿症的先进治疗方法认识有限
  • 市场区隔分析
    • 类型：研发下一代胱胺酸尿症的崛起
    • 最终用途：专科诊所对胱胺酸尿症治疗的需求正在增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章胱氨酸尿市场：依类型

  • Ⅰ型
  • II型
  • Ⅲ型

第 7 章 胱胺酸尿市场：透过提供

  • 药品
    • Captopril
    • Penicillamine
    • 硫普罗宁
  • 治疗
    • 铜注射疗法
    • 基因治疗

第八章胱胺酸尿市场：依给药途径

  • 可注射的
  • 口服

第 9 章 胱胺酸尿市场：依最终使用者分类

  • 居家护理
  • 医院
  • 专科诊所

第10章美洲胱氨酸尿市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太胱胺酸尿市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲胱胺酸尿市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 治疗胱胺酸尿症的新型缓释片剂在美国推出，并附带病患援助计划
    • FDA 核准 ADV7103 为治疗罕见肾臟病胱胺酸尿症的孤儿药
    • 新资金促进了罕见肾结石疾病胱胺酸尿症的研究
  • 战略分析和建议

公司名单

  • Advicenne SA
  • Amerigen Pharmaceuticals Limited
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cycle Pharmaceuticals Limited
  • Dr. Reddy's Laboratories
  • Lupin Limited
  • Merck & Co., Inc.
  • Orsini Specialty Pharmacy
  • Revive Therapeutics Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Travere Therapeutics, Inc.
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
Product Code: MRR-6A132FD32B22

The Cystinuria Market was valued at USD 101.56 million in 2023, expected to reach USD 106.29 million in 2024, and is projected to grow at a CAGR of 4.82%, to USD 141.30 million by 2030.

Cystinuria, a genetic disorder characterized by the formation of cystine stones in the kidneys, presents a targeted market within the broader nephrology and urological treatment sectors. The necessity for addressing cystinuria arises from its chronic nature and potential to cause recurrent nephrolithiasis, leading to renal damage if not properly managed. The application scope primarily encompasses pharmaceuticals like thiol drugs, hydration therapies, and dietary management products aimed at reducing cystine stone formation. End-use scenarios extend from hospitals and clinics to specialty pharmacies, given the need for tailored treatments and ongoing patient management.

KEY MARKET STATISTICS
Base Year [2023] USD 101.56 million
Estimated Year [2024] USD 106.29 million
Forecast Year [2030] USD 141.30 million
CAGR (%) 4.82%

Market growth is influenced by a rising prevalence of genetic disorders, advancements in genetic testing, and increased healthcare awareness regarding kidney health. However, the market faces challenges such as limited awareness about cystinuria compared to other kidney diseases, high costs associated with genetic therapies, and insufficient reimbursement policies, particularly in developing regions. Opportunities lie in enhancing patient-centric treatment models, developing non-invasive diagnostic methods, and leveraging telehealth for patient management, propelling the market forward. Companies can capitalize on these trends by investing in R&D for novel therapeutic agents, especially those with improved efficacy and safety profiles. Furthermore, fostering collaborations with healthcare providers and institutions can augment market penetration through educational initiatives and integrated care programs.

Innovations in genetic analysis and personalized medicine hold promise in advancing cystinuria treatment. The integration of artificial intelligence in predictive modeling for disease management is an exciting avenue for research. While the market is niche, its nature demands high specialization and technological advancement, creating a barrier to entry but offering substantial growth for established players or innovative newcomers. Business growth can thrive by targeting scaling opportunities in emerging markets, refining supply chain efficiencies, and ensuring comprehensive market education to improve adoption rates. Strategic recommendations include focusing on cost reduction strategies and addressing reimbursement challenges to enhance accessibility and market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystinuria Market

The Cystinuria Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of individuals diagnosed with cystinuria
    • Significant investments in genetic research and diagnostic technologies
  • Market Restraints
    • High costs associated with medication and frequent medical consultations cystinuria
  • Market Opportunities
    • Development of diagnostic tools to enable quicker and accurate detection of cystinuria
    • Governmental support for rare disease research through favorable policies
  • Market Challenges
    • Limited awareness toward advanced therapies used to treat cystinuria

Porter's Five Forces: A Strategic Tool for Navigating the Cystinuria Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystinuria Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystinuria Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystinuria Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystinuria Market

A detailed market share analysis in the Cystinuria Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystinuria Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystinuria Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cystinuria Market

A strategic analysis of the Cystinuria Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cystinuria Market, highlighting leading vendors and their innovative profiles. These include Advicenne SA, Amerigen Pharmaceuticals Limited, Amneal Pharmaceuticals LLC, Aurobindo Pharma, Bausch Health Companies Inc., Bayer AG, Cycle Pharmaceuticals Limited, Dr. Reddy's Laboratories, Lupin Limited, Merck & Co., Inc., Orsini Specialty Pharmacy, Revive Therapeutics Ltd., Teva Pharmaceutical Industries Ltd., Travere Therapeutics, Inc., and Zhejiang Huahai Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystinuria Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Type I, Type II, and Type III.
  • Based on Offering, market is studied across Medications and Therapy. The Medications is further studied across Captopril, Penicillamine, and Tiopronin. The Therapy is further studied across Copper Injection Therapy and Gene Therapy.
  • Based on Route of Administration, market is studied across Injectable and Oral.
  • Based on End-User, market is studied across Home Care, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of individuals diagnosed with cystinuria
      • 5.1.1.2. Significant investments in genetic research and diagnostic technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with medication and frequent medical consultations cystinuria
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of diagnostic tools to enable quicker and accurate detection of cystinuria
      • 5.1.3.2. Governmental support for rare disease research through favorable policies
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness toward advanced therapies used to treat cystinuria
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising R&D to develop the next generation of cystinuria
    • 5.2.2. End-use: Rising need for cystinuria therapy across specialty clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cystinuria Market, by Type

  • 6.1. Introduction
  • 6.2. Type I
  • 6.3. Type II
  • 6.4. Type III

7. Cystinuria Market, by Offering

  • 7.1. Introduction
  • 7.2. Medications
    • 7.2.1. Captopril
    • 7.2.2. Penicillamine
    • 7.2.3. Tiopronin
  • 7.3. Therapy
    • 7.3.1. Copper Injection Therapy
    • 7.3.2. Gene Therapy

8. Cystinuria Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral

9. Cystinuria Market, by End-User

  • 9.1. Introduction
  • 9.2. Home Care
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Americas Cystinuria Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cystinuria Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cystinuria Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. New Delayed-Release Tablets for Cystinuria Launched in US with Support Program for Patients
    • 13.3.2. FDA Recognizes ADV7103 as Orphan Drug for Rare Kidney Disorder Cystinuria
    • 13.3.3. New Funding Boosts Research into Rare Kidney Stone Disease Cystinuria
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advicenne SA
  • 2. Amerigen Pharmaceuticals Limited
  • 3. Amneal Pharmaceuticals LLC
  • 4. Aurobindo Pharma
  • 5. Bausch Health Companies Inc.
  • 6. Bayer AG
  • 7. Cycle Pharmaceuticals Limited
  • 8. Dr. Reddy's Laboratories
  • 9. Lupin Limited
  • 10. Merck & Co., Inc.
  • 11. Orsini Specialty Pharmacy
  • 12. Revive Therapeutics Ltd.
  • 13. Teva Pharmaceutical Industries Ltd.
  • 14. Travere Therapeutics, Inc.
  • 15. Zhejiang Huahai Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CYSTINURIA MARKET RESEARCH PROCESS
  • FIGURE 2. CYSTINURIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYSTINURIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CYSTINURIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CYSTINURIA MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CYSTINURIA MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CYSTINURIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CYSTINURIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CYSTINURIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CYSTINURIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYSTINURIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYSTINURIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CYSTINURIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CYSTINURIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CYSTINURIA MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CYSTINURIA MARKET SIZE, BY CAPTOPRIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CYSTINURIA MARKET SIZE, BY PENICILLAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CYSTINURIA MARKET SIZE, BY TIOPRONIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CYSTINURIA MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CYSTINURIA MARKET SIZE, BY COPPER INJECTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CYSTINURIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CYSTINURIA MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CYSTINURIA MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CYSTINURIA MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CYSTINURIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CYSTINURIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. CYSTINURIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 279. CYSTINURIA MARKET, FPNV POSITIONING MATRIX, 2023